A neurodevelopmental condition defined by multiple motor tics and at least one vocal tic, present for over a year and beginning before age 18.
Medically reviewed by
Dr. Mihaela G.
Tourette’s Disorder — also known as Tourette Syndrome (TS) or Gilles de la Tourette Syndrome — is a neurodevelopmental condition characterized by the presence of multiple motor tics and at least one vocal tic, both persisting for more than one year, with onset before age 18.
Tics are sudden, rapid, recurrent, non-rhythmic movements or sounds. They are the defining feature of Tourette’s Disorder and exist on a spectrum from barely noticeable to significantly disabling. Motor tics include movements such as eye blinking, head jerking, shoulder shrugging, and grimacing. Vocal tics include sounds such as throat clearing, sniffing, grunting, and — in a minority of cases — words or phrases.
One of the most persistent and damaging misconceptions about Tourette’s Disorder is that it inevitably involves involuntary swearing (coprolalia). In reality, coprolalia occurs in only approximately 10–15% of individuals with TS. The disorder is defined by the pattern of multiple motor and vocal tics, not by any particular content.
TS was first formally described by the French neurologist Georges Gilles de la Tourette in 1885, making it one of the longer-recognized neurodevelopmental conditions. Despite this, it remains widely misunderstood. Most people with Tourette’s Disorder lead full, successful lives — particularly when the tics are well-managed and co-occurring conditions are identified and treated.
Tourette’s Disorder is not chosen, faked, or controllable through willpower alone. Tics can be temporarily suppressed with significant effort — but this builds internal tension that typically leads to a rebound of more intense tics shortly afterward, much like trying to hold in a sneeze.
Tics — the core feature:
Motor tics are divided into simple and complex forms. Simple motor tics involve a single muscle group: eye blinking, head jerking, nose twitching, shoulder shrugging, neck stretching, facial grimacing. Complex motor tics involve coordinated patterns: touching or tapping objects or people, hopping, sniffing objects, obscene gestures (copropraxia), or self-injurious movements such as hitting.
Vocal tics also occur in simple and complex forms. Simple vocal tics: throat clearing (the most common), sniffing, grunting, barking, or squeaking. Complex vocal tics: repeating one’s own words (palilalia), repeating others’ words (echolalia), or uttering socially inappropriate words or phrases (coprolalia).
The premonitory urge:
One of the most clinically distinctive features of TS — and often the most distressing — is the premonitory urge: an uncomfortable, localized sensation of tension, pressure, or an “incomplete” feeling in the body that builds before a tic and is temporarily relieved by performing it. Many people describe it as similar to the urge to blink or scratch — a mounting discomfort that demands release. This urge-tic relationship is central to understanding why tics are so difficult to suppress and is also the target of the most effective behavioral treatment.
Variability and waxing/waning:
Tics characteristically wax and wane over time — changing in type, frequency, and severity across weeks and months. A tic that dominated for several months may disappear entirely, replaced by a different one. Tics are worse with fatigue, stress, excitement, and boredom, and typically diminish during focused, absorbing activity. They are often absent during sleep.
What tics are not:
Tics are not always fully involuntary — many people with TS describe them as semi-voluntary, like giving in to an itch. They are also not rhythmic (which distinguishes them from stereotypies) and are preceded by the premonitory urge (which distinguishes them from myoclonic jerks or chorea).
⋅ Anxiety and anticipatory worry about tics occurring in public or social settings
⋅ Shame or embarrassment following tics that attract attention or cause misunderstanding
⋅ Frustration from the effort of suppressing tics and the rebound that follows
⋅ Low self-esteem in adolescence, particularly when tics are severe or socially visible
⋅ Grief over the gap between who the person is and how tics make them appear to others
⋅ Emotional dysregulation, sometimes as part of the broader TS profile
⋅ The premonitory urge — uncomfortable localized tension building before each tic
⋅ Difficulty concentrating when the effort to suppress tics consumes attentional resources
⋅ Preoccupation with tic monitoring, particularly in high-scrutiny social settings
⋅ In complex tics: intrusive, unwanted thoughts that accompany or trigger specific tic sequences
⋅ Executive function difficulties, often linked to co-occurring ADHD
⋅ Repetitive, sudden motor movements affecting the face, neck, shoulders, limbs, or trunk
⋅ Involuntary sounds including throat clearing, sniffing, grunting, or vocalizations
⋅ Physical fatigue or muscle soreness in areas frequently involved in tics
⋅ Headaches or neck pain from repetitive head or neck tics
⋅ In self-injurious complex tics: bruising, skin damage, or eye irritation
⋅ Repeated eye blinking, head jerking, or facial grimacing
⋅ Shoulder shrugging, neck stretching, or whole-body movements
⋅ Throat clearing, sniffing, grunting, or other repetitive sounds
⋅ Temporarily suppressing tics in specific settings, followed by a rebound
⋅ Avoidance of social situations where tics are likely to attract attention
⋅ Tics worsening during stress, fatigue, or excitement and reducing during focused activity
⋅ Coprolalia (involuntary inappropriate words or phrases) in a minority of cases (~10–15%)
Tourette’s Disorder affects approximately 1% of school-aged children — a figure that has been consistently reported across the research literature and confirmed in epidemiological reviews covering 1986 to 2022. Among the general population across all ages, prevalence is lower (~0.3–0.9%), partly reflecting the natural tendency toward improvement in adulthood.
TS is significantly more common in males, with a male-to-female ratio of approximately 4:1. This is one of the more pronounced sex ratios in neurodevelopmental conditions, though females with TS may be underidentified. Females tend to show more internalizing features (anxiety, depression) while males are more likely to have prominent externalizing tics, which drive clinical referral.
TS occurs across all ethnicities, cultures, and socioeconomic groups, and has been reported in virtually all countries studied. There is no evidence that any cultural or environmental factor specifically causes TS, though stress and anxiety reliably worsen tic severity.
Comorbidities are the rule:
The majority of people with Tourette’s Disorder have at least one co-occurring condition. ADHD affects approximately 50% of individuals with TS and is often the source of greater functional impairment than the tics themselves. OCD co-occurs in 30–40% — with obsessions and compulsions that may overlap with or be triggered by tic-related behaviors. Anxiety disorders, depression, learning disabilities, and rage episodes are also significantly elevated. Understanding TS means understanding it as a condition that almost always arrives with company.
Tourette’s Disorder has a strong genetic basis, with heritability estimates of 0.77–0.92 from twin studies — placing it among the most heritable of all neurodevelopmental conditions.
Genetics:
TS runs strongly in families. First-degree relatives of individuals with TS have a substantially elevated risk of tic disorders. However, no single causative gene has been identified — TS, like most neurodevelopmental conditions, is polygenic. Genome-wide association studies have identified multiple risk loci, with genes involved in neuronal development, synaptic signaling, and histamine metabolism among those most implicated. Importantly, many first-degree relatives of individuals with TS have OCD or ADHD without tics — reflecting the shared genetic architecture of these conditions.
Neurobiological basis:
TS involves dysregulation of cortico-striato-thalamo-cortical (CSTC) circuits — the loops connecting the cortex, basal ganglia (particularly the striatum), thalamus, and back to the cortex that regulate voluntary movement. Specifically, there is evidence of overactive dopaminergic activity in the striatum (basal ganglia), which disrupts the inhibitory control mechanisms that normally filter out unwanted motor impulses. This model is supported by the fact that drugs that block dopamine receptors (antipsychotics) reduce tic severity, while dopamine-enhancing drugs (stimulants) sometimes worsen tics.
Environmental modifiers:
Several environmental factors modestly increase TS risk or severity: preterm birth, perinatal complications, and possibly maternal stress during pregnancy. Group A streptococcal infections have been associated with a subtype of tic exacerbation (PANDAS/PANS), though this remains an area of active research and clinical debate.
What does NOT cause TS:
Tourette’s Disorder is not caused by anxiety, poor parenting, trauma, excessive screen use, or dietary factors. These may worsen tic severity but do not produce the disorder. TS is a brain-based, largely genetically determined condition.
Diagnosis of Tourette’s Disorder is clinical — based on history, clinical observation, and sometimes video recordings. There is no blood test or brain scan used in routine diagnosis.
DSM-5-TR criteria require all of the following:
A) Both multiple motor tics AND one or more vocal tics have been present at some time, though not necessarily concurrently. B) Tics have been present for more than one year since first tic onset (with no tic-free period exceeding 3 consecutive months). C) Onset before age 18. D) Symptoms are not attributable to substances or another medical condition (including Huntington’s disease or post-viral encephalitis).
Assessment tools:
The Yale Global Tic Severity Scale (YGTSS) is the most widely used standardized rating tool — assessing the number, frequency, intensity, complexity, and interference of motor and vocal tics separately, plus an overall impairment score. It is used both for diagnosis and to track treatment response. Assessment should also include comprehensive screening for ADHD, OCD, anxiety, and learning disorders, as these frequently determine functional impairment more than tic severity alone.
Key differential diagnoses:
Stereotypic Movement Disorder (rhythmic, purposeful-feeling, ego-syntonic — unlike tics which are preceded by an urge and felt as unwanted). OCD compulsions (driven by obsessive thoughts, not a localized premonitory urge). Myoclonus (sudden, involuntary jerks without a premonitory component). Medication-induced movement disorders (tardive dyskinesia, akathisia). PANDAS/PANS (tic onset or exacerbation temporally linked to streptococcal infection, requiring specialist evaluation).
Not all tics require treatment. For mild tics that are not causing significant functional impairment or distress, the appropriate initial approach is education and watchful waiting — explaining the natural history of TS to the family, normalizing the condition, and monitoring for change. Many tics peak in childhood and improve substantially without intervention.
When tics are causing meaningful distress, academic interference, social difficulties, or physical harm, the following approaches are used:
Comprehensive Behavioral Intervention for Tics (CBIT) — first-line:
CBIT is the recommended first-line treatment for Tourette’s Disorder when intervention is needed, endorsed by the American Academy of Neurology (AAN) and European and Canadian guidelines. It combines two evidence-based strategies: Habit Reversal Training (HRT) — teaching the person to recognize the premonitory urge and produce a competing response (a muscle movement that is incompatible with the tic) until the urge subsides; and functional intervention — identifying environmental factors that worsen tics and modifying them. Two large randomized controlled trials in children and adults (Piacentini et al. 2010; Wilhelm et al. 2012) demonstrated effect sizes of SMD ≈ –0.64, and CBIT has maintained this first-line designation based on a growing body of evidence. CBIT requires a trained therapist and is generally appropriate from age 7–8 and above, when sufficient awareness and cognitive capacity are present.
Pharmacological treatment:
Medication is considered for moderate-to-severe tics, or when CBIT is unavailable or insufficient:
Alpha-2 adrenergic agonists — guanfacine and clonidine are commonly used as first-line pharmacological agents, particularly when ADHD is also present. They reduce tic severity modestly and have a favorable side-effect profile relative to antipsychotics.
Antipsychotics — aripiprazole is currently preferred due to its better tolerability profile; haloperidol, fluphenazine, and risperidone are also used. These produce the strongest tic reduction but carry risks of sedation, weight gain, metabolic effects, and — with longer-term use — tardive dyskinesia.
Valbenazine (Ingrezza) — a VMAT2 inhibitor approved by the FDA in August 2023 for the treatment of TS in adults and adolescents. It represents a new mechanism of action (reducing presynaptic dopamine release) and offers an alternative to antipsychotics.
Treating co-occurring conditions:
In many cases, treating ADHD or OCD produces greater functional improvement than treating the tics directly. Stimulants for ADHD, SSRIs for OCD, and behavioral therapies for anxiety should be part of the comprehensive treatment plan.
Understanding tics:
The single most powerful intervention for many people with TS is accurate understanding of the condition. Knowing that tics are neurological — not behavioral, not attention-seeking, not controllable through willpower — transforms the experience for both the individual and those around them. Psychoeducation for the person with TS, their family, and their school is a foundational component of management.
Managing tic triggers:
Fatigue, stress, and anxiety reliably worsen tics. Adequate sleep, stress management techniques (exercise, mindfulness, structured routines), and reducing unnecessary anxiety — including anxiety about the tics themselves — produce meaningful reductions in tic frequency and severity. A calmer internal environment is also a calmer tic environment.
Suppression and release:
Many people learn to suppress tics in specific public settings — during a job interview, an exam, a performance. This is possible but cognitively costly. Scheduling deliberate “release time” — safe, private contexts where tics can occur freely without self-monitoring — reduces the cumulative burden of suppression and decreases the rebound effect.
School and workplace:
Formal accommodations — preferential seating (to reduce awareness of tics by peers), extended time for assessments, permission to leave the room during high-tic periods, and a designated quiet space for tic release — significantly reduce the academic and social impact of TS. Many children with TS can perform at the full level of their cognitive ability with the right adjustments in place.
Community:
Organizations such as the Tourette Association of America (TAA) and the Tourettes Action (UK) provide education, support groups, youth programs, and advocacy resources. Connection with others who have TS — including adults who have navigated it successfully — is a valuable part of long-term coping.
The outlook for Tourette’s Disorder is considerably more positive than the condition’s public image suggests.
Natural history:
Tics typically begin between ages 4 and 6, increase in severity through middle childhood, and peak around age 10–12. From mid-adolescence onward, approximately 80% of individuals experience meaningful improvement in tic severity — many to a level where tics are subclinical or barely noticeable in daily life. A smaller proportion (~20%) continue to have clinically significant tics in adulthood.
What determines adult outcomes:
The severity of tics in adulthood is not predictable from childhood severity alone. However, the presence and severity of co-occurring ADHD and OCD are the strongest predictors of functional outcomes — adults with TS who also have well-managed ADHD and OCD consistently show better quality of life than those whose comorbidities are unaddressed.
Educational and occupational outcomes:
Most people with Tourette’s Disorder complete their education, pursue careers, and form relationships. TS does not limit cognitive ability and is not associated with intellectual disability. Many individuals with TS are highly successful — TS has been reported in physicians, athletes, musicians, academics, and public figures across all fields.
Quality of life:
Studies consistently find that quality of life in TS is most impaired by co-occurring anxiety, ADHD, and OCD — not by tic severity itself. This has important clinical implications: identifying and treating these comorbidities often produces greater quality-of-life improvement than tic-focused interventions alone.
Seek a clinical assessment — ideally with a child neurologist, child psychiatrist, or developmental pediatrician — if:
Not all tics require treatment. Many children with tics have presentations that are mild, transient, or minimally impairing — these can be monitored without formal intervention. An assessment clarifies the picture and guides decision-making.
If you are an adult who had tics as a child that were never formally diagnosed, or who continues to have significant tic symptoms, evaluation is worthwhile. Adult TS is increasingly recognized and treated, and both CBIT and pharmacological options are effective across the lifespan.
Someone in your life might be quietly looking for this. Share it:
These conditions share overlapping symptoms and are often misdiagnosed.
No — this is the most persistent and damaging misconception about TS. Involuntary swearing (coprolalia) occurs in only around 10–15% of people with Tourette’s Disorder. The vast majority of people with TS have motor tics (like eye blinking or shoulder shrugging) and vocal tics (like throat clearing or sniffing) that have nothing to do with swearing. Coprolalia became disproportionately associated with TS through dramatic media portrayals, but it is the exception, not the defining feature.
Partially — and with significant effort. Most people with TS can suppress tics for short periods, which is why tics often appear to reduce in clinical settings or during focused activity. But suppression is cognitively and physically tiring, and it typically leads to a rebound of more intense tics once the effort is released. Describing tic suppression as “controlling yourself” implies a level of voluntary control that is misleading — it is more like holding your breath: possible for a while, but not sustainable, and the body’s demand for release becomes stronger over time.
Probably significantly better, even if not fully. About 80% of people with TS experience meaningful improvement in tic severity by late adolescence and early adulthood. Some reach a point where tics are subclinical. A minority continue to have prominent tics into adulthood. There is no reliable way to predict which trajectory a given child will follow, but the general prognosis is considerably more optimistic than most families expect at the time of diagnosis.
Yes — closely. About half of people with TS also have ADHD, and 30–40% have OCD. This is not coincidental: these conditions share overlapping genetic risk factors and involve the same fronto-striatal brain circuits. In many cases, the ADHD or OCD causes significantly more functional difficulty than the tics themselves. This is why a thorough assessment for co-occurring conditions is just as important as diagnosing and treating the tics — and why treating only the tics often leaves the most impairing aspects of the condition unaddressed.
American Psychiatric Association. (2022). Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, Text Revision (DSM-5-TR). American Psychiatric Publishing. psychiatry.org
Gunturu, S., Saeidi, M., Alzein, O., Jafari, K., Salehi, M., & Jaka, S. (2025). Unpacking Tourette syndrome in children: Insights into prevalence and comorbidities from NSCH data. Journal of Clinical Medicine, 14(5), 1485. PMC
Piacentini, J., Woods, D. W., Scahill, L., Wilhelm, S., Peterson, A. L., Chang, S., … Walkup, J. T. (2010). Behavior therapy for children with Tourette disorder: A randomized controlled trial. JAMA, 303(19), 1929–1937. PubMed
Woods, D. W., Conelea, C. A., & Himle, M. B. (2025). Description, implementation, and efficacy of the Comprehensive Behavioral Intervention for Tics as first-line treatment for Tourette and other tic disorders. Journal of Child and Adolescent Psychopharmacology, 35(3), 126–134. PubMed
Ünalp, A., Kaya Ozer, O., & Yılmaz, U. (2025). Epidemiology of Tourette syndrome. Brain Sciences, 15(5), 426. PMC
